Crenolanib
-
Catalog numberC781795
-
PricePlease ask
-
Size1 mg
-
-
Chemical available in other sizesPlease inquire size and price
-
Stock availabilityPlease Inquire
-
Cas number670220-88-9
-
Chemical s molecular weight443.54
-
Chemical s main applicationsCrenolanib (CP-868569) is a tyrosine kinase inhibitor that acts by specifically inhibiting the receptor tyrosine kinases PDGFRα and PDGFRβ. Crenolanib (CP-868569) inhibits the activity of PDGFRα D842V kinase and prevented the phosphorylation of wild type PDGFRα. Crenolanib (CP-868569) possesses potential antineoplastic activity. Crenolanib is believed to suppress PDGFR-related signal transduction pathways leading to the inhibition of tumor angiogenesis and tumor cell proliferation.
-
Other name1-[2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine; ARO 002; CP 868596; [1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine
-
Chemical s formulaC26H29N5O2
-
Physical propertiesNo Data Available
-
Melting temperatureNo Data Available
-
Boiling temperatureNo Data Available
-
Chemical s soluble inNo Data Available
-
Stability conditionsNo Data Available
-
StorageNo Data Available
-
Gene target
-
Short nameCrenolanib
-
Alternative nameCrenolanib
-